Clinical Trials in Salt Lake City

Showing 7621-7640 of 16,694 trials

A Study to Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/Deutivacaftor

NCT05535959

The purpose of this study is to evaluate the relative bioavailability of a fixed-dose combination tablet (FDC) of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA).

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated16 participantsStarted Sep 2022

Salt Lake City, Utah, United States

COMPLETEDPhase 1< 1 mile

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

NCT03833128

The purpose of this Phase 1b study is to assess REN001 safety in subjects with fatty acid oxidation disorders.

Fatty Acid Oxidation Disorders

Reneo Pharma Ltd24 participantsStarted Apr 2019

Aurora, Colorado, United States • Portland, Oregon, United States • Pittsburgh, Pennsylvania, United States +4 more locations

COMPLETEDNA< 1 mile

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

NCT01535066

RATIONALE: Acupuncture may help relieve joint pain. PURPOSE: This randomized phase III trial studies acupuncture to see how well it works compared to sham acupuncture or waitlist in treating patients with joint pain related to aromatase inhibitors in patients with early-stage breast cancer.

Breast CancerPain

SWOG Cancer Research Network226 participantsStarted May 2012

Antioch, California, United States • Fremont, California, United States • Los Angeles, California, United States +44 more locations

A Study to Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/Deutivacaftor

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Find Trials by Condition in Salt Lake City

Naproxen Sodium/Acetaminophen Proof of Concept Dosing Study

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

RTX-321 Monotherapy in Patients With HPV 16+ Tumors

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)

DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

Physical Therapy Trial for Pelvic Pain

Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)